This is not the most recent version of the article. View current version (29 AUG 2014)

Intervention Protocol

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration

  1. MG Krzystolik,
  2. HA Woodcome,
  3. U Reddy

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 24 JAN 2005

DOI: 10.1002/14651858.CD005139


How to Cite

Krzystolik MG, Woodcome HA, Reddy U. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration (Protocol). Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD005139. DOI: 10.1002/14651858.CD005139.

Author Information

*Magdalena Krzystolik, Southern New England Retina Associates, 174 Pleasant Street, Attleboro, MA 02703, USA. Magdalena_Krzystolik@brown.edu.

Publication History

  1. Published Online: 24 JAN 2005

SEARCH

This is not the most recent version of the article. View current version (29 AUG 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of this review is to investigate the effects and acceptability of antiangiogenic therapy with anti-VEGF modalities for the treatment of neovascular age-related macular degeneration.